Related Articles
Lipoxin A4 protects against paraquat‑induced acute lung injury by inhibiting the TLR4/MyD88‑mediated activation of the NF‑κB and PI3K/AKT pathways
Effect of BML‑111 on the intestinal mucosal barrier in sepsis and its mechanism of action
Pilot application of lipoxin A4 analog and lipoxin A4 receptor agonist in asthmatic children with acute episodes
BML-111 suppresses TGF-β1-induced lung fibroblast activation in vitro and decreases experimental pulmonary fibrosis in vivo
Fisetin-treatment alleviates airway inflammation through inhbition of MyD88/NF-κB signaling pathway